Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROTECT I, A Prospective Feasibility Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI

NCT00534859 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT00534859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00534859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROTECT I, A Prospective Feasibility Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI
Lead sponsor
Abiomed Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
March 31, 2011
Enrollment
28 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

patients undergoing high risk pci.